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Abstract
Aims—The aim of this pilot study was to generate an initial estimate of the prevalence and 
correlates of diabetic retinopathy in a racially and ethnically diverse sample of youth with Type 1 
and Type 2 diabetes mellitus.
Methods—A pilot study was conducted among 222 individuals with Type 1 diabetes (79% non-
Hispanic white, 21% other) and 43 with Type 2 diabetes (28% non-Hispanic white, 72% other), all 
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of > 5 years duration (mean duration 6.8 years) who participated in the SEARCH for Diabetes in 
Youth study. Diabetic retinopathy was assessed using non-mydriatic retinal photography of both 
eyes.
Results—The prevalence of diabetic retinopathy was 17% for Type 1 diabetes and 42% for Type 
2 diabetes (odds ratio 1.50, 95% CI 0.58–3.88; P = 0.40 adjusted for age, duration, gender, race/
ethnicity, parental education and HbA1c. HbA1c was significantly higher among those with any 
diabetic retinopathy (adjusted mean 79 mmol/mol, 9.4%) vs. no diabetic retinopathy (adjusted 
mean 70 mmol/mol, 8.6%) (P = 0.015). LDL cholesterol was also significantly higher among 
those with any diabetic retinopathy (adjusted mean 107.2 mg/dl) compared with those without 
diabetic retinopathy (adjusted mean 97.9 mg/dl) (P = 0.04).
Conclusions—The prevalence of diabetic retinopathy in contemporary young individuals was 
substantial, particularly among minority youth and those with Type 2 diabetes. Further long-term 
study of diabetic retinopathy in youth is needed.
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Introduction
Data on the epidemiology of diabetic retinopathy in youth with diabetes are limited. 
Estimates of the prevalence of diabetic retinopathy among individuals with Type 1 diabetes 
vary from 4.6% among youth in France (mean duration 4.8 years) [1] to 20% among youth 
from Australia (mean duration 6.8 years) [2]. Interestingly, the prevalence of diabetic 
retinopathy among Australian youth with Type 1 diabetes declined signifcantly over three 
time periods (1990–1994, 1995–1998 and 1999–2002) from 49% in the first time period to 
31% in the second time period, and 24% in the third time period [3]. A recent study from 
Finland reported prevalence of diabetic retinopathy of 12% among youth with Type 1 
diabetes (mean duration 4.9 years), with no decrease in prevalence over a 17-year period [4]. 
Therefore, it is important to determine the prevalance of diabetic retinopathy in a 
contemporary cohort of youth with Type 1 diabetes.
For youth with Type 2 diabetes, the published literature is very limited, with only one small 
study identified: in the Australian cohort, prevalence was 4% (n = 25, mean duration 1.3 
years) [2]. It is also important to consider potential differences in prevalence according to 
race/ethnicity. From the most recent national estimate of prevalence of diabetic retinopathy 
among adults with diabetes in the USA [5], non-Hispanic white individuals had a crude 
prevalence of 26%; compared with 39 and 34% for non-Hispanic black and Hispanic 
individuals, respectively.
The SEARCH for Diabetes in Youth study comprises the largest contemporary cohort of 
youth with diabetes studied in the USA, with substantial racial and ethnic diversity. Here, 
we report findings from a pilot study of the prevalence and correlates of diabetic retinopathy 
in youth with either Type 1 or Type 2 diabetes who participated in SEARCH.
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SEARCH includes individuals diagnosed with diabetes before the age of 20 years from six 
centres, whose diabetes was prevalent in 2001 or incident thereafter. Study methods [6] and 
the study cohort have been described [7]. Briefly, following medical record-based validation 
of the diabetes diagnosis and study eligibility, youth with diabetes or their parent/guardians 
were asked to complete a short initial survey that collected information on race and 
ethnicity, and diabetes-related factors. Self-reported race and ethnicity were collected using 
the 2000 US Census questions [8]. All youths who replied to the initial survey, excluding 
those whose diabetes was secondary to other conditions, were invited to a study visit during 
which questionnaires were administered, a brief physical examination was conducted and 
biological specimens were collected. Specific laboratory methods for these tests have been 
previously described [9,10]. All measures were conducted under standardized protocols by 
centrally trained and certified research staff. Youths with diabetes incident in 2002–2005 
were invited to the baseline examination, plus up to three follow-up visits scheduled up to 
60 months after baseline.
A pilot study to assess diabetic retinopathy prevalence and correlates was conducted from 
December 2009 to September 2010 to inform plans for the SEARCH Cohort Study, which 
will commence in 2011. A convenience sample of incident cases (2002–2005) with ≥ 5 
years of diabetes duration who were attending a SEARCH 60-month follow-up visit during 
the diabetic retinopathy pilot study time period were eligible. Diabetes duration and HbA1c 
did not differ between individuals who participated in the diabetic retinopathy pilot and 
those who attended a 60-month follow-up visit but who, primarily because of being outside 
the calendar time allotted for the diabetic retinopathy pilot, did not participate (P > 0.5 for 
both). Diabetic retinopathy was determined by grading 45° colour digital fundus images 
centred on the disc and macula of both eyes taken using a non-mydriatic camera (Visucam 
Pro N; Carl Zeiss Meditech, Jena, Germany) under a standardized protocol. The University 
of Wisconsin Ocular Epidemiology Reading Center (RK) was responsible for conduct of 
centralized training and certification of study staff, quality control of retinal photos and 
reading of the photos for diabetic retinopathy presence and severity. Diabetic retinopathy 
severity was based on the worse eye and categorized as none, minimal non-proliferative 
diabetic retinopathy, mild–moderate nonproliferative diabetic retinopathy to proliferative 
[11]. Institutional review board(s) for each of the centres approved the study protocol.
Generalized linear models and logistic regression were used to evaluate correlates of 
diabetic retinopathy and adjust for diabetes type, race/ethnicity, duration, HbA1c, gender, 
age and parental education; with statistical significance established at P < 0.05.
Results
Participants included 222 individuals with physician-diagnosed Type 1 diabetes (176 non-
Hispanic white, 46 other race/ethnicity) and 43 with Type 2 diabetes (12 non-Hispanic 
white, 31 other race/ethnicity) (Table 1). Figure 1 shows prevalence of diabetic retinopathy 
by severity within subgroups of diabetes type and race/ethnicity. The prevalence of any 
diabetic retinopathy was 42% for those with Type 2 diabetes [mean age 21.1 years (sd 2.8); 
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mean time since diagnosis 7.2 years (sd 0.93)] compared with 17% for Type 1 diabetes 
[mean age 16.0 years (sd 4.4); mean time since diagnosis 6.8 years (sd 0.97)]. For both Type 
1 and Type 2 diabetes, crude prevalence of both minimal diabetic retinopathy and mild-to-
proliferative diabetic retinopathy was lower among non-Hispanic white indiviudals 
compared with those of other race/ethnicities.
Because of small numbers in some cells, all subsequent analyses to adjust for potential 
confounding compare ‘any diabetic retinopathy’ vs. ‘no diabetic retinopathy’. Shown in 
Table 1, the difference in prevalence of diabetic retinopathy by diabetes type was not 
statistically significant (odds ratio 1.50, 95% CI 0.58–3.88; P = 0.40). The observed higher 
prevalence of diabetic retinopathy among minority youth was not fully explained by 
differences in HbA1c or other potential confounders, including duration of disease (odds 
ratio 2.05, 95% CI 0.97–4.33); however, the criteria for statistical significance was not 
satisfied (P = 0.06). HbA1c was significantly higher among those with any diabetic 
retinopathy (adjusted mean 79 mmol/mol, 9.4%) vs. no diabetic retinopathy (adjusted mean 
70 mmol/mol, 8.6%) (P = 0.015). LDL cholesterol was significantly higher among those 
with any diabetic retinopathy (adjusted mean 107.2 mg/dl) than those without diabetic 
retinopathy (adjusted mean 97.9 mg/dl) (P = 0.04).
Discussion
From this pilot study, the estimate of prevalence of diabetic retinopathy among those with 
Type 1 diabetes (17%) was similar to that reported from Australia [2] from a cohort of 
similar duration. For those with Type 2 diabetes, we report a high prevalence of diabetic 
retinopathy (42%), which was surprising and may reflect high risk for diabetic retinopathy 
in population subgroups. Most (72%) of the SEARCH participants with Type 2 diabetes in 
the present study were of minority race/ethnicity and, from previous studies that also used 
retinal photography, high prevalence of diabetic retinopathy can be detected in non-
Caucasian populations such as Pima Indians [12] or individuals with Type 2 diabetes from 
the island of Mauritius [13]. Of note, for the combined group of Type 1 and Type 2 diabetes, 
the higher prevalence of diabetic retinopathy among minority youth was not fully explained 
by differences in HbA1c or other potential confounders, including duration of disease. 
Interestingly, in Japan, individuals with early onset of Type 2 diabetes (< 30 years) appeared 
to have higher incidence of diabetic retinopathy, and greater risk for progression from 
background diabetic retinopathy to proliferative diabetic retinopathy [14], as well as higher 
incidence of diabetic nephropathy compared with individuals with Type 1 diabetes [15]. 
Thus, in the USA, minority youth who develop Type 2 diabetes relatively early in life may 
be particularly vulnerable to development of the microvascular complications of diabetes.
Regarding associations of diabetic retinopathy with clinical variables, findings across studies 
are mixed [16,17] and further research is needed. From the Australian cohort, higher systolic 
and diastolic blood pressures were associated with development of background retinopathy, 
after adjustment for albumin excretion rate, HbA1c, duration of diabetes, age and height 
[16]. Cheung et al. [17] reported that, among young individuals with Type 1 diabetes, longer 
duration of diabetes, lower BMI and higher HbA1c were significantly associated with 
incidence of diabetic retinopathy, as was larger retinal arteriolar caliber; however, 
Mayer-Davis et al. Page 4













differences in mean arterial blood pressure, gender and albumin excretion rate did not 
significantly predict diabetic retinopathy. In the present study, higher HbA1c and higher 
LDL cholesterol concentrations were the strongest correlates of diabetic retinopathy, 
independent of diabetes type and other covariates.
This pilot study suggests that, despite advances in diabetes care, diabetic retinopathy 
remains an important concern both in terms of research and clinical care. The present results 
are preliminary, as is the nature of pilot studies. Motivated by these findings, the SEARCH 
Cohort Study will assess diabetic retinopathy in an estimated 3000 individuals with Type 1 
or Type 2 diabetes who have previously participated in at least one SEARCH visit, inclusive 
of diverse race/ethnicities. Such studies will be critically important to advance our 
knowledge of the burden and correlates of diabetic retinopathy among youth, particularly 
those with Type 2 diabetes and those of minority race/ethnicity, and will provide much-
needed evidence for the development of screening guidelines in contemporary youth with 
diabetes.
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Prevalence and severity of diabetic retinopathy among participants in the SEARCH for 
Diabetes in Youth diabetic retinopathy pilot study: n = 222 with Type 1 diabetes and n = 43 
with Type 2 diabetes. For proliferative diabetic retinopathy: n = 0 for Type 1 diabetes; n = 1 
for Type 2 diabetes.
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Table 1
Overall generalized linear model results for youth with Type 1 (n =222) and Type 2 diabetes (n = 43)
*
Potential risk factor
† Odds ratio (95% CI) P-value
Diabetes type (Type 2 vs. Type 1) 1.50 (0.58-3.88) 0.40
Race/ethnicity (Non-white vs. non-Hispanic white) 2.05 (0.97-4.33) 0.06
No diabetic retinopathy Diabetic retinopathy, any severity P-value
Duration (years) 6.9 7.1 0.25
HbA1c 70 mmol/mol 79 mmol/mol 0.015
8.6% 9.4%
Systolic blood pressure (mmHg) 106.3 107.1 0.66
Diastolic blood pressure (mmHg) 65.0 67.4 0.13
Log albumin-to-creatinine ratio 2.1 2.3 0.31
BMI 25.2 26.1 0.23
Height (m) 1.47 1.48 0.88
NHANES waist circumference (cm) 86.9 89.2 0.32
Total cholesterol (mg/dl) 170.0 180.0 0.10
LDL cholesterol (mg/dl) 97.9 107.2 0.04
HDL cholesterol (mg/dl) 49.3 48.4 0.71
Log triglycerides 4.5 4.6 0.22
*
Numbers vary slightly because of occasional missing data.
†
Adjusted for diabetes type, race/ethnicity, diabetes duration, HbA1c, gender, age and parental education.
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